Angelousi Anna, Jouinot Anne, Bourgioti Charis, Tokmakidis Panagiotis, Bertherat Jérôme, Kaltsas Gregory
First Department of Internal Medicine, Unit of Endocrinology, Laikon Hospital, Center of Excellence of Endocrine Tumours, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Université de Paris, Institut Cochin, Department of Endocrinology, Referral Center for Rare Adrenal Diseases, INSERM U-1016, CNRS UMR- 8104, 75014 Paris, France.
JCEM Case Rep. 2024 Jul 30;2(8):luae131. doi: 10.1210/jcemcr/luae131. eCollection 2024 Aug.
The transformation of an adrenocortical adenoma (ACA) to an adrenocortical carcinoma (ACC) is extremely rare. Current guidelines suggest against further imaging studies and follow-up in patients with nonfunctional adrenal incidentalomas (NFAIs) with benign imaging characteristics. Herein, we present a 64-year-old male patient diagnosed initially with a NFAI of 3 cm in size with imaging characteristics consistent with an ACA. However, 13 years after initial diagnosis, this apparent ACA developed into a high-grade cortisol and androgen-secreting ACC with synchronous metastases. The literature review revealed a further 9 case reports of adrenal incidentalomas initially characterized as ACA that subsequently developed into ACC within a period ranging from 1 to 10 years. The pathogenesis of transformation of an initially denoted ACA to ACC is not fully delineated, although the existing literature focuses on the preexisting or changing genetic background of these lesions, highlighting the need to develop robust prognostic markers to identify patients at risk and individualize the follow-up of these unique cases.
肾上腺皮质腺瘤(ACA)转变为肾上腺皮质癌(ACC)极为罕见。当前指南建议,对于具有良性影像学特征的无功能肾上腺偶发瘤(NFAI)患者,无需进一步进行影像学检查及随访。在此,我们报告一例64岁男性患者,最初诊断为大小3 cm的NFAI,其影像学特征与ACA相符。然而,在初次诊断13年后,这个看似为ACA的病变发展成了伴有同步转移的高分级皮质醇和雄激素分泌性ACC。文献回顾显示,另有9例肾上腺偶发瘤的病例报告,这些病例最初被诊断为ACA,随后在1至10年的时间内发展为ACC。尽管现有文献关注这些病变预先存在或变化的基因背景,但最初诊断为ACA转变为ACC的发病机制尚未完全阐明,这凸显了开发可靠的预后标志物以识别高危患者并对这些特殊病例进行个体化随访的必要性。